Production and Characterization of Rat Monoclonal Antibodies against the PAL Antigen of Legionella spp. 2022

N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
State Scientific Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Moscow oblast Russia.

The purpose of this work was to obtain genus-specific monoclonal antibodies against the Legionella spp. recombinant PAL protein, which will subsequently allow to use them as a basis for the development of new express tests for pathogenic legionella detection. A short three-week immunization protocol for Wistar rats was used to generate rat-mouse heterohybridomas producing antibodies against PAL. Mouse myeloma cell line Sp2/0-Ag14 served as the fusion partner. Hybridization was performed using two methods: PEG-mediated fusion and electrofusion. Subsequent screening was performed by indirect solid-phase ELISA against the target protein rPAL. Specificity analysis was performed by dot-blot using a panel of lysates obtained from 39 pure cultures of different strains, which included closely related and heterologous microorganisms among others. No difference in the efficiency of stable hybridoma clones production by the two indicated cell-fusion methods was detected. Twelve clones producing specific rat monoclonal antibodies were obtained based on the screening results. The obtained rat monoclonal antibodies are highly specific towards the PAL protein of L. pneumophila of different serological groups and other pathogenic legionella and are good candidates to be used as the components of diagnostic test systems for the detection of pathogenic representatives of the Legionella genus.

UI MeSH Term Description Entries

Related Publications

N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 1993, Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 1991, Biomedica biochimica acta,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
July 1989, Journal of reproductive immunology,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 2015, Avicenna journal of medical biotechnology,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
June 1998, Hybridoma,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 1985, Microbiology and immunology,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 1982, Journal of virology,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
January 1992, Acta cientifica venezolana,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
September 1990, Thrombosis research,
N A Zeninskaya, and A K Riabko, and M A Marin, and T I Kombarova, and I P Mitsevich, and B V Yeruslanov, and V V Firstova, and I G Shemyakin
June 2020, Journal of acupuncture and meridian studies,
Copied contents to your clipboard!